Mirvetuximab soravtansine and low-grade serous ovarian cancer: innovation awaiting validation

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Robert Louis Coleman, Brian M. Slomovitz

DOI: 10.1016/j.ijgc.2025.104453

Cited by: 0

References: 4

Fields of Study & Subjects

PARP inhibition in cancer therapy Ovarian cancer diagnosis and treatment HER2/EGFR in Cancer Research

References 4